RE: THAT COVID STUDY17 May 2021 18:01
When you see how other covid related stocks have multi bagged over the last year, Sar has a potential treatment for long covid among many other respiratory treatments in the bag , best in class Tyk2,, 1081 & 1082, serria holds onto Sar737. The ducks a lined up nicely for all LTHs. We all know why and what we are here for. Nytc, Sng will have nothing on this beauty.